Patent US2722033A successfully refreshed from Google Patents.
Patent US4553972A successfully refreshed from Google Patents.
US4553972A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Disposable intravaginal contraceptive devices releasing 1-substituted imidazoles
Assignee: Syntex USA LLC
•
Filing: 1983-05-20
•
Granted: 1985-11-19
•
Expires: 2003-05-20
Abstract
Abstract Devices, of suitable form and size for insertion into the vagina of a female mammal, composed of a polymeric material which has, incorporated in it, a 1-substituted imidazole spermicide and a pharmaceutically acceptable chelating agent, and which release effective amounts of said spermicide while in place in the vaginal cavity, are useful as contraceptives.
Inventors
- 👤 Brian H. Vickery
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-31 19:15
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0034; A61K9/0036; A61F; A61F6/00; A61F6/06; A61F6/08
Claims Analysis
Total Claims: 16
Claim 1
Independent Claim
495 words
A contraceptive device which releases spermicide and a pharmaceutically acceptable chelating agent during intravaginal placement in a female mammal comprising (a) an inert, flexible polymeric material formed into a configuration suitable for vaginal insertion and long term retention in the vagina and permeable to the release of said spermicide and a pharmaceutically acceptable chelating agent; (b) an effective amount of a 1-substituted imidazole spermicide or the pharmaceutically acceptable acid addition salts thereof, included within the matrix of said polymeric material, the imidazole having the formula ##STR3## wherein: (i) R is alkyl of one to twelve carbon atoms, phenyl or phenyl-lower-alkyl of one to four carbon atoms wherein the phenyl ring is optionally substituted by one or more lower alkyl of one to four carbon atoms, lower alkoxy of one to four carbon atoms, halo or trifluoromethyl; R 2 together with R 3 is ethylenedithio or propylenedithio wherein the alkylene chain is optionally substituted by one lower alkyl of one to four carbon atoms; and n is 1, 2 or 3; (ii) R is cycloalkyl of five to seven carbon atoms or cycloalkylalkyl of six to ten carbon atoms; R 2 is hydrogen or lower alkyl of one to four carbon atoms; R 3 is alkyl of two to twelve carbon atoms, cycloalkyl of five to seven carbon atoms or cycloalkylalkyl of six to ten carbon atoms; and n is 1, 2 or 3; (iii) R is phenyl or phenyl-lower-alkyl of one to three carbon atoms wherein the phenyl ring is optionally substituted by one or more lower alkyl of one to four carbon atoms, lower alkoxy of one to four carbon atoms, halo or trifluoromethyl; R 2 is hydrogen or lower alkyl of one to four carbon atoms; R 3 is alkyl of one to twelve carbon atoms, phenyl-lower-alkyl of one to three carbon atoms wherein the phenyl ring is optionally substituted by one or more lower alkyl of one to four carbon atoms, lower alkoxy of one to four carbon atoms, halo, or trifluoromethyl; and n is 1, 2 or 3; (iv) R is alkyl of one to twelve carbon atoms; R 2 is hydrogen or lower alkyl of one to four carbon atoms; R 3 is hydrogen or alkyl of one to twelve carbon atoms; and n is 1, 2, 3 or 4; or (v) R and R 4 are each alkyl of one to twelve carbon atoms, alkenyl of two to twelve carbon atoms, phenyl, phenyl-lower-alkyl of one to four carbon atoms or phenyl-lower-alkyl of two to four carbon atoms wherein the phenyl ring is optionally substituted by one or more lower alkyl of one to four carbon atoms, lower alkoxy of one to four carbon atoms, halo, or trifluoromethyl; R 2 is hydrogen or lower alkyl of one to four carbon atoms; R 3 and X-R 4 wherein X is oxygen or sulfur; and n is 1, 2 or 3; and (c) an effective amount of a pharmaceutically acceptable chelating agent.
Claim 2
Dependent Claim
495 words
A contraceptive device which releases spermicide and a pharmaceutically acceptable chelating agent during intravaginal placement in a female mammal comprising (a) an inert, flexible polymeric material formed into a configuration suitable for vaginal insertion and long term retention in the vagina and permeable to the release of said spermicide and a pharmaceutically acceptable chelating agent; (b) an effective amount of a 1-substituted imidazole spermicide or the pharmaceutically acceptable acid addition salts thereof, included within the matrix of said polymeric material, the imidazole having the formula ##STR3## wherein: (i) R is alkyl of one to twelve carbon atoms, phenyl or phenyl-lower-alkyl of one to four carbon atoms wherein the phenyl ring is optionally substituted by one or more lower alkyl of one to four carbon atoms, lower alkoxy of one to four carbon atoms, halo or trifluoromethyl; R 2 together with R 3 is ethylenedithio or propylenedithio wherein the alkylene chain is optionally substituted by one lower alkyl of one to four carbon atoms; and n is 1, 2 or 3; (ii) R is cycloalkyl of five to seven carbon atoms or cycloalkylalkyl of six to ten carbon atoms; R 2 is hydrogen or lower alkyl of one to four carbon atoms; R 3 is alkyl of two to twelve carbon atoms, cycloalkyl of five to seven carbon atoms or cycloalkylalkyl of six to ten carbon atoms; and n is 1, 2 or 3; (iii) R is phenyl or phenyl-lower-alkyl of one to three carbon atoms wherein the phenyl ring is optionally substituted by one or more lower alkyl of one to four carbon atoms, lower alkoxy of one to four carbon atoms, halo or trifluoromethyl; R 2 is hydrogen or lower alkyl of one to four carbon atoms; R 3 is alkyl of one to twelve carbon atoms, phenyl-lower-alkyl of one to three carbon atoms wherein the phenyl ring is optionally substituted by one or more lower alkyl of one to four carbon atoms, lower alkoxy of one to four carbon atoms, halo, or trifluoromethyl; and n is 1, 2 or 3; (iv) R is alkyl of one to twelve carbon atoms; R 2 is hydrogen or lower alkyl of one to four carbon atoms; R 3 is hydrogen or alkyl of one to twelve carbon atoms; and n is 1, 2, 3 or 4; or (v) R and R 4 are each alkyl of one to twelve carbon atoms, alkenyl of two to twelve carbon atoms, phenyl, phenyl-lower-alkyl of one to four carbon atoms or phenyl-lower-alkyl of two to four carbon atoms wherein the phenyl ring is optionally substituted by one or more lower alkyl of one to four carbon atoms, lower alkoxy of one to four carbon atoms, halo, or trifluoromethyl; R 2 is hydrogen or lower alkyl of one to four carbon atoms; R 3 and X-R 4 wherein X is oxygen or sulfur; and n is 1, 2 or 3; and (c) an effective amount of a pharmaceutically acceptable chelating agent.
Claim 3
Dependent Claim
21 words
The device of claim 1 wherein the configuration is that of a ring of suitable size to fit into the vagina.
Claim 4
Dependent Claim
21 words
The device of claim 1 wherein the configuration is that of a diaphragm of suitable size to fit into the vagina.
Claim 5
Dependent Claim
14 words
The device of claim 1 wherein the configuration is that of a cervical cap.
Claim 6
Dependent Claim
14 words
The device of claim 1 wherein the polymeric material is formed from silicone elastomer.
Claim 7
Dependent Claim
35 words
The device of claim 1 wherein said polymeric material is formed by polymerization carried out in the presence of an effective amount of the spermicide and an effective amount of a pharmaceutically acceptable chelating agent.
Claim 8
Dependent Claim
79 words
The device of claim 1 comprising (a) an inert, flexible polymeric material formed into a configuration suitable for vaginal insertion and long term retention in the vagina and permeable to the release of said spermicide and a pharmaceutically acceptable chelating agent; (b) between 0.5% and 5% of the 1-substituted imidazole spermicide or the pharmaceutically acceptable acid addition salts thereof, included within the matrix of said polymeric material; and (c) between 0.1% and 0.75% of a pharmaceutically acceptable chelating agent.
Claim 9
Dependent Claim
38 words
A device of claim 7 wherein the pharmaceutically acceptable chelating agent is selected from the group consisting of polyacid derivatives of ethylenediamine, enamine derivatives of amino acids, and compounds containing hydroxy or phenolic hydroxy group and carboxy groups.
Claim 10
Dependent Claim
17 words
A device of claim 8 wherein the pharmaceutically acceptable chelating agent is a polyacid derivative of ethylenediamine.
Claim 11
Dependent Claim
14 words
A device of claim 9 wherein the pharmaceutically acceptable chelating agent is ethylenediaminetetraacetic acid.
Claim 12
Dependent Claim
23 words
The device of claim 10 wherein the spermicide is selected from the group consisting of 1-[(3,3-ethylenedithio)-n-octyl]imidazole; 1-[(3,3-ethylenedithio)-n-decyl]imidazole; 1-[(3,3-ethylenedithio)-n-dodecyl]imidazole; 1-[(2,2-ethylenedithio)-n-octyl]imidazole; 1-[(2,2-ethylenedithio)-n-octyl]imidazole; 1-[(2,2-ethylenedithio)-n-decyl]imidazole; and 1-[(2,2-ethylenedithio)-n-dodecyl]imidazole.
Claim 13
Dependent Claim
23 words
The device of claim 10 wherein the spermicide is selected from the group consisting of 1-(2-cyclohexylmethyl-n-hexyl)imidazole; 1-(2-cyclohexyl-n-hexyl)imidazole; 1-[2-methyl-2-(cyclohexylmethyl)-n-hexyl)imidazole; 1-[2-propyl-2-(cyclohexylmethyl)-n-pentyl]imidazole; 1-(3-cyclohexylmethyl)-n-heptyl)imidazole; 1-(4-cyclohexylmethyl)-n-octyl)imidazole; and 1-[2-cyclohexylmethyl)-3-cyclohexyl-n-propyl]-imidazole.
Claim 14
Dependent Claim
22 words
The device of claim 10 wherein the spermicide is selected from the group consisting of 1-[2-(2-(2-chlorophenyl)ethyl)-n-hexyl]imidazole; 1-[2-(2-(4-chlorophenyl)ethyl)-n-hexyl]imidazole; 1-[2-(2-(4-methylphenyl)ethyl)-n-hexyl]imidazole; 1-(2-benzyl-n-heptyl)imidazole; 1-[2-(2-phenylethyl-n-octyl)imidazole; and 1-[2-(2-(4-methylphenyl)ethyl)-n-octyl]imidazole.
Claim 15
Dependent Claim
22 words
The device of claim 10 wherein the spermicide is selected from the group consisting of 1-(n-decyl)imidazole; 1-(n-dodecyl)imidazole; 1-(3-propyl-n-heptyl)imidazole; 1-(2-propyl-n-octyl)imidazole; 1-(4-n-butyl-n-octyl)imidazole; and 1-(3-n-pentyl-n-nonyl)imidazole.
Claim 16
Dependent Claim
10 words
The device of claim 10 wherein the spermicide is 1-[2-(2,4-dichlorobenzyloxy)-n-octyl]imidazole.
References Cited (Backward Citations)
US3991760A
Cited
US3995633A
Cited
US4198976A
Cited
US4311543A
Cited
US4215691A
Cited
US4304226A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1988-11-18 | 1989-05-20 | 1989-11-19 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1992-11-18 | 1993-05-20 | 1993-11-19 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1996-11-18 | 1997-05-20 | 1997-11-19 | $7700.00 | Window Closed / Lapsed |